Casma Therapeutics
Autophagy pathway modulation platform for treating neurodegenerative diseases and lysosomal storage disorders
- Sector
- Biotech
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 38 pending · first 2026
- Rank in peer group#481 of 1449
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextStanding among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#481 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 39- GrantedTrpml ModulatorsUSPTOUS 12,698,266
- PendingTrpml ModulatorsUSPTOApplication 18019638
- PendingMethods Of Tfeb Activation And Lysosomal Biogenesis And Compositions ThereforUSPTOApplication 18019275
Show all 39 patent records
- Trpml ModulatorsAug 4, 2026 · US 12,698,266Granted
- Trpml ModulatorsDec 28, 2023 · Application 18019638Pending
- Methods Of Tfeb Activation And Lysosomal Biogenesis And Compositions ThereforAug 31, 2023 · Application 18019275Pending
- Trpml ModulatorsApr 6, 2023 · Application 17786607Pending
- Compounds And Methods For Promoting AutophagyApplication PCTUS2024057948Pending
- Bifunctional Degraders And Uses ThereofApplication PCTUS2024030957Pending
- Bicyclic Heteroaromatic Compounds As Trpml ModulatorsApplication 63564383Pending
- Ulk Complex Modulators And Uses ThereofApplication 63605373Pending
- Compounds And Methods For Promoting AutophagyApplication 63605364Pending
- Ulk Complex Modulators And Uses ThereofApplication 63605380Pending
- Compounds And Methods For Inhibiting AutophagyApplication 63605371Pending
- Bifunctional Degraders And Uses ThereofApplication 63469124Pending
- Trpml ModulatorsApplication PCTUS2021044911Pending
- Methods Of Tfeb Activation And Lysosomal Biogenesis And Compositions ThereforApplication PCTUS2021043125Pending
- Trpml ModulatorsApplication 63186846Pending
- Methods Of Tfeb Activation And Lysosomal Biogenesis And Compositions ThereforApplication 63150520Pending
- Trpml ModulatorsApplication PCTUS2020065845Pending
- Trpml ModulatorsApplication PCTUS2020065851Pending
- Trpml ModulatorsApplication PCTUS2020065839Pending
- Trpml ModulatorsApplication 63119907Pending
- Trpml ModulatorsApplication 63119915Pending
- Trpml ModulatorsApplication 63119895Pending
- Bifunctional Degraders And Uses ThereofApplication 19487524Pending
- Trpml ModulatorsApplication 63119888Pending
- TRPML1 ModulatorsApplication 63062943Pending
- Methods Of Tfeb Activation And Lysosomal Biogenesis And Compositions ThereforApplication 63060611Pending
- TRPML1 ModulatorsApplication 62950818Pending
- TRPML1 ModulatorsApplication 62950768Pending
- TRPML1 ModulatorsApplication 62950799Pending
- TRPML1 ModulatorsApplication 62950807Pending
- Ulk Complex Modulators And Uses ThereofApplication 19591807Pending
- Ulk Complex Modulators And Uses ThereofApplication 19591788Pending
- Compounds And Methods For Promoting AutophagyApplication 19591822Pending
- Compounds And Methods For Inhibiting AutophagyApplication 19591829Pending
- Bicyclic Heteroaromatic Compounds As Trpml ModulatorsApplication PCTUS2025019362Pending
- Bicyclic Heteroaromatic Compounds As Trpml ModulatorsApplication 19623265Pending
- Compounds And Methods For Inhibiting AutophagyApplication PCTUS2024057953Pending
- Ulk Complex Modulators And Uses ThereofApplication PCTUS2024057956Pending
- Ulk Complex Modulators And Uses ThereofApplication PCTUS2024057958Pending
Related companies, and why
- Biophysical Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- AegisCN LLCSimilar federal contract value in Biotech · null in contracts
- SAROS THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts
- ProTexase Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Aquavit Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
- InVivo Therapeutics CorpSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .